Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 24 shown

Structural formula: Trimipramine mesylate

Commercialized according to BDPM

SURMONTIL 4 %, oral solution, vial

Active ingredients: Trimipramine mesylate, Trimipramine

Oral solution in drops

Original BDPM details in French

Official name: SURMONTIL 4 POUR CENT, solution buvable, flacon
Active ingredients: MÉSILATE DE TRIMIPRAMINE, TRIMIPRAMINE BASE
Package description: 1 flacon(s) en verre brun de 30 ml avec fermeture de sécurité enfant

CIS 63905138CIP7 3102250CIP13 3400931022503

View details

Estimated price€15.70No current ANSM shortage notice is included

Commercialized according to BDPM

EXTOVYL, hard capsule

Active ingredients: BÉTAHISTINE (MÉSILATE DE)

Original BDPM details in French

Official name: EXTOVYL, gélule
Active ingredients: BÉTAHISTINE (MÉSILATE DE)
Package description: pilulier(s) en verre de 60 gélule(s)

CIS 60887044CIP7 3225099CIP13 3400932250998

View details

Estimated price€11.00No current ANSM shortage notice is included

Commercialized according to BDPM

SURMONTIL 100 mg, film-coated tablet scored

Active ingredients: TRIMIPRAMINE (MALÉATE ACIDE DE), Trimipramine

Original BDPM details in French

Official name: SURMONTIL 100 mg, comprimé pelliculé sécable
Active ingredients: TRIMIPRAMINE (MALÉATE ACIDE DE), TRIMIPRAMINE BASE
Package description: plaquette(s) thermoformée(s) PVC-Aluminium de 20 comprimé(s)

CIS 64868034CIP7 3102267CIP13 3400931022671

View details

Estimated price€23.12No current ANSM shortage notice is included

Commercialized according to BDPM

SURMONTIL 25 mg, tablet

Active ingredients: TRIMIPRAMINE (MALÉATE ACIDE DE), Trimipramine

Original BDPM details in French

Official name: SURMONTIL 25 mg, comprimé
Active ingredients: TRIMIPRAMINE (MALÉATE ACIDE DE), TRIMIPRAMINE BASE
Package description: plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 50 comprimé(s)

CIS 63344192CIP7 3102296CIP13 3400931022961

View details

Estimated price€14.60No current ANSM shortage notice is included

Structural formula: Deferoxamine mesylate

Commercialized according to BDPM

DESFERAL 500 mg, powder and solvent for solution for injection

Active ingredients: Deferoxamine mesylate

Original BDPM details in French

Official name: DESFERAL 500 mg, poudre et solvant pour solution injectable
Active ingredients: MÉSILATE DE DÉFÉROXAMINE
Package description: 1 flacon(s) en verre de 500 mg - 1 ampoule(s) en verre de 5 ml

CIS 68537836CIP7 3029837CIP13 3400930298374

View details

Estimated price€12.60No current ANSM shortage notice is included

Commercialized according to BDPM

VECTARION INJECTABLE, lyophilizate and solution for injection preparation

Active ingredients: Almitrine mesylate

Original BDPM details in French

Official name: VECTARION INJECTABLE, lyophilisat et solution pour préparation injectable
Active ingredients: ALMITRINE (MÉSILATE D')
Package description: 12 flacon(s) - 12 ampoule(s) de 5 ml

CIS 60047143CIP7 3214279CIP13 3400932142798

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AZILECT 1 mg, tablet

Active ingredients: Rasagiline mesylate, Rasagiline

Original BDPM details in French

Official name: AZILECT 1 mg, comprimé
Active ingredients: MÉSILATE DE RASAGILINE, RASAGILINE
Package description: plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)

CIS 62722988CIP7 3657835CIP13 3400936578357

View details

Estimated price€69.64No current ANSM shortage notice is included

Commercialized according to BDPM

AZILECT 1 mg, tablet

Active ingredients: Rasagiline mesylate, Rasagiline

Original BDPM details in French

Official name: AZILECT 1 mg, comprimé
Active ingredients: MÉSILATE DE RASAGILINE, RASAGILINE
Package description: plaquette(s) thermoformée(s) aluminium de 30 comprimé(s) (distributeur parallèle : BB FARMA s.r.l)

CIS 62722988CIP7 4950050CIP13 3400949500505

View details

Estimated price€69.64No current ANSM shortage notice is included

Commercialized according to BDPM

CAMCEVI 42 mg, suspension for injection with extended release

Active ingredients: LEUPRORÉLINE, MÉSILATE DE LEUPRORÉLINE

Original BDPM details in French

Official name: CAMCEVI 42 mg, suspension injectable à libération prolongée
Active ingredients: LEUPRORÉLINE, MÉSILATE DE LEUPRORÉLINE
Package description: 1 seringue(s) préremplie(s) copolymère de cyclooléfines (COC) avec aiguille(s) sécurisée(s)

CIS 65867330CIP7 3025568CIP13 3400930255681

View details

Estimated price€779.94No current ANSM shortage notice is included

Structural formula: Dihydroergotamine mesylate

Commercialized according to BDPM

DIERGOSPRAY 4 mg/ml, solution as a nasal spray

Active ingredients: Dihydroergotamine mesylate

Solution for spraying

Original BDPM details in French

Official name: DIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasale
Active ingredients: MÉSILATE DE DIHYDROERGOTAMINE
Package description: 1 flacon(s) en verre brun de 1 ml avec dispositif pulvérisateur (PULVADOZ) polypropylène

CIS 62455371CIP7 3473822CIP13 3400934738227

View details

Estimated price€11.06No current ANSM shortage notice is included

Commercialized according to BDPM

DIVARIUS 20 mg, film-coated tablet scored

Active ingredients: Paroxetine mesylate, Paroxetine

Original BDPM details in French

Official name: DIVARIUS 20 mg, comprimé pelliculé sécable
Active ingredients: MÉSILATE DE PAROXÉTINE, PAROXÉTINE
Package description: plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 14 comprimé(s)

CIS 68085224CIP7 3601125CIP13 3400936011250

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

DIVARIUS 20 mg, film-coated tablet scored

Active ingredients: Paroxetine mesylate, Paroxetine

Original BDPM details in French

Official name: DIVARIUS 20 mg, comprimé pelliculé sécable
Active ingredients: MÉSILATE DE PAROXÉTINE, PAROXÉTINE
Package description: plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)

CIS 68085224CIP7 3601131CIP13 3400936011311

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE ARROW LP 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE ARROW LP 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s) en conditionnement calendaire

CIS 65525280CIP7 2165567CIP13 3400921655674

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE SUBSTIPHARM LP 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE SUBSTIPHARM LP 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s)

CIS 61689364CIP7 2165366CIP13 3400921653663

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE SUBSTIPHARM LP 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE SUBSTIPHARM LP 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s) en conditionnement calendaire

CIS 66978789CIP7 2165679CIP13 3400921656794

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE TEVA LP 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE TEVA LP 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) thermoformée(s) PVC PVDC aluminium de 28 comprimé(s)

CIS 67970560CIP7 3944641CIP13 3400939446417

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE VIATRIS L.P. 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE VIATRIS L.P. 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) aluminium de 28 comprimé(s)

CIS 60562606CIP7 3762561CIP13 3400937625616

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE VIATRIS L.P. 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE VIATRIS L.P. 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) aluminium de 28 comprimé(s)

CIS 67020316CIP7 3762578CIP13 3400937625784

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

FINLEE 10 mg, dispersible tablet

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: FINLEE 10 mg, comprimé dispersible
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 210 comprimé(s) avec 2 gobelet(s) doseur(s)

CIS 61606482CIP7 3028119CIP13 3400930281192

View details

Estimated price€3,606.10No current ANSM shortage notice is included

Commercialized according to BDPM

KISPLYX 10 mg, hard capsule

Active ingredients: Lenvatinib, Lenvatinib mesylate

Original BDPM details in French

Official name: KISPLYX 10 mg, gélule
Active ingredients: LENVATINIB, MÉSILATE DE LENVATINIB
Package description: plaquette(s) polyamide aluminium PVC-Aluminium de 30 gélule(s)

CIS 69503274CIP7 3007496CIP13 3400930074961

View details

Estimated price€2,590.08No current ANSM shortage notice is included

Commercialized according to BDPM

KISPLYX 4 mg, hard capsule

Active ingredients: Lenvatinib, Lenvatinib mesylate

Original BDPM details in French

Official name: KISPLYX 4 mg, gélule
Active ingredients: LENVATINIB, MÉSILATE DE LENVATINIB
Package description: plaquette(s) polyamide aluminium PVC-Aluminium de 30 gélule(s)

CIS 67913602CIP7 3007495CIP13 3400930074954

View details

Estimated price€2,590.08No current ANSM shortage notice is included

Commercialized according to BDPM

LENVIMA 10 mg, hard capsule

Active ingredients: Lenvatinib, Lenvatinib mesylate

Original BDPM details in French

Official name: LENVIMA 10 mg, gélule
Active ingredients: LENVATINIB, MÉSILATE DE LENVATINIB
Package description: 3 plaquette(s) polyamide aluminium PVC-Aluminium de 10 gélule(s)

CIS 64456664CIP7 3001895CIP13 3400930018958

View details

Estimated price€2,774.32No current ANSM shortage notice is included

Commercialized according to BDPM

LENVIMA 4 mg, hard capsule

Active ingredients: Lenvatinib, Lenvatinib mesylate

Original BDPM details in French

Official name: LENVIMA 4 mg, gélule
Active ingredients: LENVATINIB, MÉSILATE DE LENVATINIB
Package description: 3 plaquette(s) polyamide aluminium PVC-Aluminium de 10 gélule(s)

CIS 62093424CIP7 3001894CIP13 3400930018941

View details

Estimated price€2,774.32No current ANSM shortage notice is included

Commercialized according to BDPM

LOJUXTA 10 mg, capsules

Active ingredients: Lomitapide, Lomitapide mesylate

Hard capsule

Original BDPM details in French

Official name: LOJUXTA 10 mg, gélules
Active ingredients: LOMITAPIDE, MÉSILATE DE LOMITAPIDE
Package description: flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)

CIS 69243759CIP7 2762607CIP13 3400927626074

View details

Estimated price€41,222.16No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.